HeartMate
Device
Abbott Laboratories
Total Payments
$914,366
Transactions
6,037
Doctors
2,476
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $140,651 | 725 | 396 |
| 2019 | $323,501 | 1,708 | 982 |
| 2018 | $450,214 | 3,604 | 1,677 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $458,727 | 330 | 50.2% |
| Food and Beverage | $276,680 | 5,350 | 30.3% |
| Travel and Lodging | $70,534 | 306 | 7.7% |
| Grant | $51,000 | 4 | 5.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $50,394 | 42 | 5.5% |
| Unspecified | $5,000 | 1 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $1,950 | 2 | 0.2% |
| Education | $49.60 | 1 | 0.0% |
| Gift | $31.98 | 1 | 0.0% |
Payments by Type
General
$909,366
6,036 transactions
Research
$5,000
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hemostatic abnormalities as risk factors of thrombosis in heartmate LVAD implanted patients of the prevent study | Abbott Laboratories | $5,000 | 0 |
Ad
Manufacturing Companies
- Abbott Laboratories $914,366
Product Information
- Type Device
- Total Payments $914,366
- Total Doctors 2,476
- Transactions 6,037
About HeartMate
HeartMate is a device associated with $914,366 in payments to 2,476 healthcare providers, recorded across 6,037 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2020. In 2020, $140,651 was paid across 725 transactions to 396 doctors.
The most common payment nature for HeartMate is "Consulting Fee" ($458,727, 50.2% of total).
HeartMate is associated with 1 research study, including "Hemostatic abnormalities as risk factors of thrombosis in heartmate LVAD implanted patients of the prevent study" ($5,000).